Sutro Biopharma, Inc.
USD32.82
-0.53 (-1.59%)
CEO
Jane Chung
IPO Date
2018-09-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$33.45
Prev. Close
$33.35
Day Low
$32.59
Day High
$33.62
52W Low
$6.70
52W High
$43.85
Market Cap
$0.32B
Volume
0.03M
| -0.6 |
| 31 Dec 2023 | FY | 95.6% | -69.5% | -71.4% | -22.7% | 0.22 | 4.50 | -2.4 |
| 31 Dec 2022 | FY | 87.8% | -175.9% | -54.9% | -29.3% | 0.25 | 5.31 | -3.4 |
| 31 Dec 2021 | FY | 84.2% | -170.6% | -41.8% | -30.9% | 0.23 | 5.24 | -6.5 |
| 31 Dec 2020 | FY | -80.1% | -75.2% | -9.7% | -8.2% | 0.07 | 12.78 | -22.0 |
| 31 Dec 2019 | FY | 100.0% | -130.4% | -57.0% | -35.6% | 0.10 | 3.90 | -4.5 |
| 31 Dec 2018 | FY | -41.2% | -91.9% | -26.8% | -15.8% | 0.11 | 5.76 | -5.8 |
| 31 Dec 2017 | FY | -0.3% | -38.1% | 18.1% | -48.3% | -0.13 | 0.80 | -5.4 |
| 31 Dec 2016 | FY | 27.1% | 2.8% | -1.9% | 2.5% | -0.01 | 0.99 | 3.9 |
| -0.5 |
| 30 Sept 2025 | Q3 | 100.0% | -586.6% | 65.2% | -27.1% | -0.20 | 2.53 | -0.3 |
| 30 Jun 2025 | Q2 | 100.0% | -18.0% | 35.8% | -4.4% | -6.84 | 3.12 | -1.3 |
| 31 Mar 2025 | Q1 | 100.0% | -436.6% | 294.3% | -23.6% | -0.83 | 2.16 | -0.2 |
| 31 Dec 2024 | Q4 | 100.0% | -489.2% | -162.4% | -18.7% | 0.52 | 2.60 | -0.5 |
| 30 Sept 2024 | Q3 | 100.0% | -572.6% | -43.9% | -10.8% | 0.22 | 3.09 | -1.5 |
| 30 Jun 2024 | Q2 | 93.0% | -186.8% | -31.6% | -9.8% | 0.17 | 3.41 | -1.3 |
| 31 Mar 2024 | Q1 | 86.5% | -447.5% | -59.4% | -14.4% | 0.29 | 4.46 | -1.4 |
| 31 Dec 2023 | Q4 | 100.0% | 27.3% | 20.8% | 6.6% | 0.22 | 4.50 | 2.1 |